Cenegermin: A Review in Neurotrophic Keratitis
Sign Up to like & getrecommendations! Published in 2020 at "Drugs"
DOI: 10.1007/s40265-020-01289-w
Abstract: Cenegermin (Oxervate™), an ophthalmic solution containing 20 µg/mL of recombinant human nerve growth factor (rhNGF), is the first drug to be approved for the treatment of neurotrophic keratitis (NK; also referred to as neurotrophic keratopathy). In… read more here.
Keywords: neurotrophic keratitis; cenegermin review; treatment; corneal healing ... See more keywords